Literature DB >> 2646253

Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients.

M Wang1, X Z Gu, W B Yin, G J Huang, L J Wang, D W Zhang.   

Abstract

From June 1977 to May 1985, a prospective randomized clinical trial on pre-operative radiation for esophageal carcinoma was carried out in 206 patients. Lesions under 8 cm in length and patients younger than 65 years, at least on semi-liquid diet and not contra-indicated for surgery were randomized into a combined group (104 patients) or a surgery alone group (102 patients). Eight MV X ray units were used for the pre-operative radiation using A-P portals to deliver 4,000 cGy to the whole mediastinum and the left gastroepiploic lymphatic chain. Surgery was carried out after 2 to 4 week's rest. The immediate results of the combined group and the surgery alone group were: resection rate 93% and 85%, operative mortality 5% and 6%, intra-thoracic anastomotic leak 0% and 1%, positive pathology at the esophageal stump 0% and 2%, and lymph nodes metastasis 27% and 35% respectively. The 5-year survival rates of the combined group and the surgery alone group were 35% and 30%. We have noticed that those patients with lesions showing radiation reaction of grade III gave a 5-year survival of 50% (12/24). Because intra- and extra-thoracic lymphnode metastasis caused failures (41% and 34% of these two groups), increasing the preoperative tumor dose to 60 Gy or designing post-operative irradiation to cover the bilateral supraclavicular areas was necessary. The whole mediastinum and the left gastroepiploic lymphatics could further improve the results of surgery. Further studies are needed.

Entities:  

Mesh:

Year:  1989        PMID: 2646253

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

Review 1.  Neoadjuvant treatment of esophageal cancer.

Authors:  Nicholas P Campbell; Victoria M Villaflor
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

2.  [Neoadjuvant therapy for squamous cell carcinoma of the esophagus].

Authors:  F Lordick
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

Review 3.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

Review 4.  Squamous cell carcinoma of the oesophagus: 10 years on.

Authors:  G A Khoury
Journal:  Ann R Coll Surg Engl       Date:  1991-01       Impact factor: 1.891

Review 5.  Perioperative therapy for esophageal cancer.

Authors:  Makoto Yamasaki; Hiroshi Miyata; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-29

6.  Surgery for esophageal cancer after concomitant radiochemotherapy: oncologic and functional results.

Authors:  Nicolas Plaisant; Pierre Senesse; David Azria; Claire Lemanski; Marc Ychou; Francois Quenet; Bernard Saint-Aubert; Philippe Rouanet
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

7.  A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy.

Authors:  B Dunne; J V Reynolds; E Mulligan; A Kelly; M Griffin
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

Review 8.  Adjuvant therapies for cancer of the thoracic esophagus.

Authors:  T Nishihira; T Nakano; S Mori
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

9.  The role of radiation therapy in resected T2 N0 esophageal cancer: a population-based analysis.

Authors:  Jeremiah T Martin; Mathias Worni; Joseph B Zwischenberger; Beat Gloor; Ricardo Pietrobon; Thomas A D'Amico; Mark F Berry
Journal:  Ann Thorac Surg       Date:  2012-10-11       Impact factor: 4.330

Review 10.  Multimodality approach for locally advanced esophageal cancer.

Authors:  Khaldoun Almhanna; Jonathan R Strosberg
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.